Background
Methods
Study settings and selection of study sites
Sample size estimation
Data collection
Data analysis
Results
Availability of the medicines
Medicines (N = 21 classes) | Availability (%) | Diagnostic tests (N = 19) | Availability (%) |
---|---|---|---|
UFH | 20.1 | Microalbuminuria | 6.8 |
Isosorbide mono nitrate | 27.8 | Serum ketones | 11.4 |
LMWH | 31.9 | Serum natriuretic peptides | 11.4 |
Intermediate insulin | 34.7 | Echocardiography | 34.1 |
Hydralazine | 47.2 | Coagulation profile | 36.4 |
Pre mixed insulin | 60.1 | Serum troponin testing | 43.2 |
Warfarin | 64.6 | HbA1c testing | 43.2 |
Soluble insulin | 68.8 | Thyroid function tests | 43.2 |
ARB-thiazide diuretics | 82.6 | Electrocardiography | 54.6 |
Digoxin | 84.0 | Uric acid testing | 56.8 |
Statins | 84.0 | Lipid profile | 65.9 |
ARB | 86.8 | Creatinine | 86.4 |
Spironolactone | 87.5 | Urea | 86.4 |
Benzathine penicillin | 87.5 | Serum electrolytes | 88.6 |
Furosemide | 89.6 | Chest X-ray | 88.6 |
Thiazide diuretics | 94.4 | Liver function tests | 95.5 |
Anti platelet drugs | 95.1 | Glucometers | 97.7 |
ACEI | 96.5 | CBC testing | 97.7 |
Beta blockers | 97.2 | Urinalysis | 100 |
CCB | 99.3 | ||
OHA | 100 |
Availability of the diagnostic tests
Comparison of the availability of selected medicines in the different study sites
Availability of the medicines in % | ||||
---|---|---|---|---|
Medicines | Private hospitals (n = 23) | Public hospitals (n = 22) | Private pharmacy (n = 100) |
P value |
A: Medicines with a statistically significant difference between study sites | ||||
ARBs | 87.0 | 31.8 | 99.0 | <0.001 |
ARB-thiazide diuretics | 78.3 | 27.3 | 96.0 | <0.001 |
Statins | 87.0 | 18.2 | 98.0 | <0.001 |
Warfarin | 65.2 | 18.2 | 74.8 | <0.001 |
Soluble insulin | 100 | 81.8 | 58.6 | <0.001 |
Thiazide diuretics | 82.6 | 95.5 | 97.0 | 0.025 |
Spironolactone | 91.3 | 68.2 | 90.9 | 0.012 |
LMWH | 47.8 | 9.1 | 33.3 | 0.018 |
UFH | 39.1 | 4.6 | 19.2 | 0.014 |
Isosorbide mono nitrate | 30.4 | 4.6 | 32.3 | 0.030 |
B: Medicines with no statistically significant difference between study sites | ||||
Captopril | 91.3 | 95.5 | 98.0 | 0.277 |
CCB | 95.7 | 100 | 100 | 0.071 |
Beta blockers | 95.6 | 100 | 97.0 | 0.650 |
Anti platelet drugs | 91.3 | 91.0 | 97.0 | 0.317 |
Digoxin | 91.3 | 81.2 | 82.3 | 0.579 |
Pre mixed insulin | 69.6 | 77.3 | 54.1 | 0.080 |
Intermediate insulin | 43.5 | 27.3 | 34.3 | 0.516 |
Benzathine penicillin | 91.3 | 100 | 83.8 | 0.097 |
Loop duiretics | 91.3 | 100 | 86.9 | 0.182 |
Hydralazine | 65.2 | 45.6 | 43.4 | 0.166 |
OHA | 100 | 100 | 100 | 1 |
Comparison of the availability of selected diagnostic tests in public and private hospitals
Availability of the tests (%) | |||
---|---|---|---|
Test | Private hospitals (n = 23) | Public hospitals (n = 24) |
P value |
A: Diagnostic tests with a statistically significant difference between study sites | |||
Lipid profile | 86.4 | 45.5 | 0.004 |
HbA1c | 63.6 | 22.7 | 0.006 |
Uric acid | 77.3 | 36.4 | 0.006 |
Serum troponin | 68.2 | 18.2 | 0.001 |
Coagulation profile | 59.1 | 13.6 | 0.002 |
Thyroid function tests | 72.7 | 13.6 | <0.001 |
B: Diagnostic tests with no statistically significant difference between study sites | |||
Serum creatinine | 95.5 | 77.3 | 0.079 |
Serum urea | 95.5 | 77.3 | 0.079 |
Glucometers | 100 | 95.5 | 0.312 |
Serum electrolytes | 95.5 | 81.8 | 0.154 |
Serum ketones | 13.6 | 9.1 | 0.635 |
Microalbuminuria | 4.6 | 9.1 | 0.550 |
CBC | 95.5 | 100 | 0.312 |
Serum natriuretic peptides | 18.2 | 4.6 | 0.154 |
Echocardiography | 45.5 | 22.7 | 0.112 |
Chest X-ray | 95.5 | 81.8 | 0.154 |
Liver function tests | 100 | 90.9 | 0.148 |
Electrocardiography | 54.5 | 54.5 | 1 |
Urinalysis | 100 | 100 | NA |
Affordability of the study medicines and diagnostic tests of interest
Selected medicines
Medicine (N = 37) | Median (IQR) price/tab in Ug Shs | Median price/tab in USD | IRP in USD | MPR | Monthly cost in USD | Days’ wagesc
|
---|---|---|---|---|---|---|
A: Affordable drugs according to calculated days’ wages (≤ 3) | ||||||
Benzathine penicillin 2.4 MU | 1500 (1500–2000) | 0.42 | 0.3241 | 1.2 | 0.4 | 0.3 |
Furosemide tablet 40 mg | 100 (100–100) | 0.02 | 0.0061 | 3.3 | 0.6 | 0.5 |
Glibenclamide 5 mg | 100 (100–200) | 0.03 | 0.0042 | 7.1 | 0.9 | 0.7 |
Bendrofluazide 5 mg | 100 (100–100) | 0.03 | 0.0072 | 4.2 | 0.9 | 0.7 |
Atenolol 50 mg | 100 (100–200) | 0.03 | 0.0106 | 2.8 | 0.9 | 0.7 |
Cardiac aspirin 75 mg | 150 (150–200) | 0.04 | 0.0196 | 2.0 | 1.2 | 0.9 |
Digoxin tablet 0.25 mg | 200 (200–300) | 0.06 | 0.0148 | 4.1 | 1.8 | 1.4 |
Metformin 500 mg | 200 (200–300) | 0.06 | 0.0168 | 3.6 | 3.6 | 2.8 |
Captopril 25 mg | 200 (200–300) | 0.06 | 0.0216 | 2.8 | 3.6 | 2.8 |
Nifedipine 20 mg | 200 (100–250) | 0.06 | 0.0233 | 2.6 | 3.6 | 2.8 |
B: Unaffordable drugs according to the calculated days’ wages (> 3) | ||||||
Amlodipine 5 mg | 500 (400–500) | 0.14 | 0.0321 | 4.4 | 4.2 | 3.2 |
Warfarin 5 mg | 500 (500–500) | 0.14 | 0.0369 | 3.8 | 4.2 | 3.2 |
Glimepiride 2 mg | 500 (400–1000) | 0.14 | – | – | 4.2 | 3.2 |
Spironolactone 25 mg | 500 (400–600) | 0.14 | 0.0398 | 3.5 | 4.2 | 3.2 |
Furosemide i.v vial 20 mg | 1000 (1000–1500) | 0.28 | 0.0623 | 4.5 | 4.2 | 3.2 |
Hydralazine tablet 25 mg | 300 (225–450) | 0.08 | 0.0376 | 2.1 | 4.8 | 3.7 |
Telmisartan 40 mg | 600 (500–800) | 0.17 | – | – | 5.1 | 3.9 |
Bisoprolol 5 mg | 600 (500–800) | 0.17 | – | – | 5.1 | 3.9 |
Pioglitazone 30 mg | 600 (500–800) | 0.17 | – | – | 5.1 | 3.9 |
Losartan 50 mg | 700 (600–800) | 0.19 | 0.2443 | 0.8 | 5.7 | 4.4 |
Soluble insulin 1vial | 22,000 (20000–25,000) | 6.11 | 0.7723 | 7.9 | 6.1 | 4.7 |
Amlodipine 10 mg | 750 (700–800) | 0.21 | 0.1414 | 1.5 | 6.3 | 4.9 |
Intermediate insulin 1vial | 23,000 (20000–25,000) | 6.39 | 0.7723 | 8.3 | 6.4 | 4.9 |
Pre mixed insulin 1vial | 23,000 (21000–25,000) | 6.39 | 0.6143 | 10.4 | 6.4 | 4.9 |
Clopidogrel 75 mg | 800 (700–1100) | 0.22 | 0.0736 | 3.0 | 6.6 | 5.1 |
Losartan H 62.5 mg | 800 (700–900) | 0.22 | – | – | 6.6 | 5.1 |
Telmisartan H 52.5 mg | 800 (700–1000) | 0.22 | – | – | 6.6 | 5.1 |
Nebivolol 5 mg | 1000 (900–1300) | 0.28 | – | – | 8.4 | 6.5 |
Simvastatin 20 mg | 1000 (900–1500) | 0.28 | 0.0252 | 11.1 | 8.4 | 6.5 |
Isosorbide mono-nitrate 10 mg | 1000 (985–1600) | 0.28 | 0.0705 | 4.0 | 8.4 | 6.5 |
Atovastatin 20 mg | 1200 (1000–2000) | 0.33 | 0.0640 | 5.2 | 9.9 | 7.6 |
Rosuvastatin 10 mg | 1200 (1000–2000) | 0.33 | – | – | 9.9 | 7.6 |
Carvedilol 6.25 mg | 700 (600–900) | 0.19 | 0.0445 | 4.3 | 11.4 | 8.8 |
Metformin 1000 mg | 700 (500–800) | 0.19 | – | – | 11.4 | 8.8 |
UFHb 5000 units | 20,000 (18000–20,000) | 5.56 | 0.9055 | 6.1 | 50.0 | 38.5 |
LMWHa 60 mg | 38,500 (34500–45,000) | 10.69 | 2.8751 | 3.7 | 53.5 | 41.2 |
LMWHa 80 mg | 50,000 (45000–60,000) | 13.89 | 5.8025 | 2.4 | 69.5 | 53.5 |
Median cost, pricing of the available LPG medicines and their comparison with the available originator medicines
Originator medicine (OM) | Median (IQR) price of OM in UgX | Median (IQR) price of OM in USD | Name of LPG medicine | Median (IQR) of the LPG medicine (UgX) | Median (IQR) price of LPG in USD |
---|---|---|---|---|---|
Micardis 40 mg | 3700 (2000–4000) | 1.0 (0.6–1.1) | Telmisartan 40 mg | 600 (500–800) | 0.2 (0.1–0.2) |
Co-Micardis 40/12.5 mg | 4000 (2000–4500) | 1.1 (0.6–1.3) | Telmisartan-H | 800 (700–1000) | 0.2 (0.2–0.3) |
Adalat 30 mg | 2000 (1500–2500) | 0.6 (0.5–0.7) | Nifedipine 20 mg | 200 (100–250) | 0.1 (0.02–0.1) |
Norvasc 5 mg | 1000 (1000–2600) | 0.3 (0.3–0.7) | Amlodipine 5 mg | 500 (400–500) | 0.1 (0.1–0.1) |
Norvasc 10 mg | 1500 (1250–2800) | 0.4 (0.3–0.8) | Amlodipine 10 mg | 750 (700–800) | 0.2 (0.2–0.2) |
Concor 5 mg | 2500 (1800–2500) | 0.7 (0.5–0.7) | Bisoprolol 5 mg | 600 (500–800) | 0.2 (0.1–0.2) |
Lipitor 20 mg | 3000 (2000–4000) | 0.8 (0.6–1.1) | Atovastatin 20 mg | 1200 (1000–2000) | 0.3 (0.3–0.6) |
Crestor 10 mg | 3000 (2500–3500) | 0.8 (0.7–1) | Rosuvastatin 10 mg | 1200 (1000–2000) | 0.3 (0.3–0.6) |
Bayer aspirin 100 mg | 400 (300–500) | 0.1 (0.1–0.1) | Cardiac aspirin 75 mg | 150 (150–200) | 0.04 (0.04–0.1) |
Glucophage 500 mg | 400 (300–500) | 0.1 (0.1–0.1) | Metformin 500 mg | 200 (200–300) | 0.1 (0.1–0.1) |
Glucophage 1000 mg | 600 (525–800) | 0.2 (0.2–0.2) | Metformin 1000 mg | 700 (500–800) | 0.2 (0.1–0.2) |
Amaryl 2 mg | 1800 (1000–2000) | 0.5 (0.3–0.6) | Glimepiride 2 mg | 500 (400–1000) | 0.1 (0.1–0.3) |
Actrapid 1 vial | 23,000 (22000–25,000) | 6.4 (6.1–6.9) | Soluble insulin 1 vial | 22,000 (20000–25,000) | 6.1 (5.6–6.9) |
Insulitard 1 vial | 23,000 (22000–25,000) | 6.4 (6.1–6.9) | Intermediate insulin | 23,000 (20000–25,000) | 6.4 (5.6–6.9) |
Mixtard 1 vial | 23,000 (22000–25,000) | 6.4 (6.1–6.9) | Pre mixed insulin | 23,000 (21000–25,000) | 6.4 (5.8–6.9) |
Clexane 60 mg | 42,000 (35000–46,800) | 11.7 (9.7–13) | LMWH 60 mg | 38,500 (34500–45,000) | 10.7 (9.6–12.5) |
Clexane 80 mg | 60,000 (55000–69,000) | 16.7 (15.3–19.2) | LMWH 80 mg | 50,000 (45000–60,000) | 13.9 (12.5–16.7) |
Selected diagnostic tests
Test | Median (IQR) price in UgX | Median price in USD | Monthly cost in USD | Days’ wages for test |
---|---|---|---|---|
A: Affordable diagnostic tests | ||||
RBG | 5000 (5000–6950) | 1.4 | 1.4 | 1.1 |
Urinalysis | 6250 (5000–10,000) | 1.7 | 1.7 | 1.3 |
Serum ketones | 10,000 (10000–10,000) | 2.8 | 2.8 | 2.1 |
Serum uric acid | 10,000 (10000–15,500) | 2.8 | 2.8 | 2.1 |
Serum urea | 11,000 (10000–19,900) | 3.1 | 3.1 | 2.4 |
Serum creatinine | 11,000 (10000–20,000) | 3.1 | 3.1 | 2.4 |
B: Unaffordable diagnostic tests | ||||
CBC | 15,000 (13000–20,000) | 4.2 | 4.2 | 3.2 |
Serum electrolytes | 25,000 (15000–30,000) | 6.9 | 6.9 | 5.3 |
Coagulation profile | 30,000 (20000–30,000) | 8.3 | 8.3 | 6.4 |
Chest X-ray | 30,000 (25000–45,000) | 8.3 | 8.3 | 6.4 |
Lipid profile | 35,000 (30000–41,000) | 9.7 | 9.7 | 7.5 |
Liver function tests | 36,000 (27500–47,850) | 10.0 | 10.0 | 7.7 |
Serum HbA1c | 40,000 (35000–40,000) | 11.1 | 11.1 | 8.6 |
Microalbuminuria | 45,000 (45000–45,000) | 12.5 | 12.5 | 9.6 |
Electrocardiography | 50,000 (40000–52,000) | 13.8 | 13.8 | 10.7 |
Serum troponin | 53,000 (45000–60,000) | 14.7 | 14.7 | 11.3 |
Thyroid function tests | 100,000(77500–149,000) | 27.8 | 27.8 | 21.4 |
Echocardiography | 155,000 (100000–175,000) | 43.1 | 43.1 | 33.1 |
Serum natriuretic peptides | 190,000 (150000–275,000) | 52.8 | 52.8 | 40.6 |